Anzeige
Mehr »
Login
Mittwoch, 04.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Analysten eilen, um Kursziele zu verdreifachen nach ATHAs neuester Entdeckung
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire (Europe)-Archiv vom 11.07.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
11.07.Q-Linea AB: Interim report 1 January - 30 June 202424ASTar launches in the US market Second quarter: 1 April-30 June 2024Net sales amounted to SEK 0.2 million (1.4).The operating result totalled SEK -65.3 million (-64.6).The result for the period amounted...
► Artikel lesen
11.07.Bonesupport Holding AB: Bonesupport Holding AB (publ) - publishes Q2 2024 Interim report35BONESUPPORT HOLDING AB (publ), a leading company in orthobiologics for the management of bone injuries, today publishes the interim report for the second quarter 2024. 55% SALES GROWTH IN THE FIRST...
► Artikel lesen
11.07.Bufab AB: Interim report January - June 202435Weaker demand, improved gross margin and stable cash flow. Divestment of manufacturing companies. Second quarter of 2024•Net sales declined by -6.0 percent to SEK 2,142 million (2,280). Organic growth...
► Artikel lesen
11.07.SuRo Capital Corp. Second Quarter 2024 Preliminary Investment Portfolio Update115NEW YORK, July 11, 2024 (GLOBE NEWSWIRE) -- SuRo Capital Corp. ("SuRo Capital", the "Company", "we", "us", and "our") (Nasdaq: SSSS) today provided the following preliminary update on its investment...
► Artikel lesen
11.07.Qomolangma Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Filing of Quarterly Report on Form 10-Q227New York, NY, July 11, 2024 (GLOBE NEWSWIRE) -- Qomolangma Acquisition Corp. (Nasdaq: QOMO) (the "Company") announced that it has received a notice (the "Notice") from The Nasdaq Stock Market LLC...
► Artikel lesen
11.07.SIM Acquisition Corp. I Completes $230.0 Million Initial Public Offering111NEW YORK, July 11, 2024 (GLOBE NEWSWIRE) -- SIM Acquisition Corp. I (the "Company") announced today the closing of its initial public offering of 23,000,000 units, which includes 3,000,000 units issued...
► Artikel lesen
11.07.Stack Capital Group Inc.: Stack Capital Holding Hopper Partners With Japanese-Based SMBC Group300TORONTO, July 11, 2024 (GLOBE NEWSWIRE) -- Stack Capital Group Inc., (TSX:STCK) is pleased to announce that Hopper, Inc. ("Hopper"), an existing portfolio holding, has announced a partnership with...
► Artikel lesen
11.07.DHT Holdings, Inc. Business Update328HAMILTON, BERMUDA, July 11, 2024 - DHT Holdings, Inc. (NYSE:DHT) ("DHT" or the "Company") today provides the following business update: For the second quarter of 2024, the Company estimates time charter...
► Artikel lesen
11.07.Diana Shipping Inc. Announces Time Charter Contract for m/v Atalandi With Cargill300ATHENS, Greece, July 11, 2024 (GLOBE NEWSWIRE) -- Diana Shipping Inc. (NYSE: DSX), (the "Company"), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels...
► Artikel lesen
11.07.Rhythm Pharmaceuticals, Inc.: Rhythm Pharmaceuticals Announces New Employment Inducement Grants170BOSTON, July 11, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families...
► Artikel lesen
11.07.Eos Energy Enterprises, Inc.: Eos Energy Announces Compliance with Nasdaq Continued Listing Criteria311EDISON, N.J., July 11, 2024 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ: EOSE) ("Eos" or the "Company"), a leading provider of safe, scalable, efficient, and sustainable zinc-based long...
► Artikel lesen
11.07.Nurix Therapeutics, Inc.: Nurix Therapeutics Reports Second Quarter Fiscal 2024 Financial Results and Provides a Corporate Update839Presented positive clinical data at the European Hematology Association Congress supporting a potential best-in-class profile for NX-5948 for the treatment of CLL Strengthened leadership with appointment...
► Artikel lesen
11.07.Janover Inc.: Janover Reports Profitability and Over 700% Monthly Increase in Operating Margins for Groundbreaker Platform in May 2024182BOCA RATON, Fla., July 11, 2024 (GLOBE NEWSWIRE) -- Janover Inc. (Nasdaq: JNVR) ("Janover" or the "Company"), an AI-enabled platform for commercial real estate transactions, today provided an update...
► Artikel lesen
11.07.Teck Resources Ltd: Teck Announces Completion of Steelmaking Coal Sale141VANCOUVER, British Columbia, July 11, 2024 (GLOBE NEWSWIRE) -- Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) ("Teck") today announced that it has completed the sale of its remaining...
► Artikel lesen
11.07.Decklar Resources Inc.: Revocation of Management Cease Trade Order and Implementation of Cease Trade Order226CALGARY, Alberta, July 11, 2024 (GLOBE NEWSWIRE) -- Decklar Resources Inc. (TSX-V: DKL) (OTC: DKLRF) (FSE: A1U1) (the "Company" or "Decklar") today announces that the Alberta Securities Commission...
► Artikel lesen
11.07.Tevogen Bio Inc: Tevogen Bio Issues Letter to Stockholders Highlighting Recent Achievements, Growth Plans, and Consideration of a Potential Share Buyback121WARREN, N.J., July 11, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holding Inc. ("Tevogen" or "Tevogen Bio") (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf...
► Artikel lesen
11.07.Pepco Group N.V.: Third Quarter FY24 Trading Update7.401Pepco Group, the fast-growing variety discount retailer, which owns the Pepco and Dealz brands in Europe and Poundland in the UK, today reports a trading update for its third financial quarter of FY24...
► Artikel lesen
11.07.Novotech: New Report Highlights Global Trends and Advances in Chronic Lymphocytic Leukemia Research and Treatment517BOSTON, July 11, 2024. This expert monthly report, provided by the Novotech research analyst team, is free of charge. It highlights promising new developments in CLL research and therapies, offering...
► Artikel lesen
11.07.TGS ASA: TGS Webcast Details for Q2 2024 Presentation321OSLO, Norway (11 July 2024) - TGS will release its Q2 2024 results at approximately 07:00 CEST on 18 July 2024. CEO Kristian Johansen and CFO Sven Børre Larsen will present the results at 09:00 CEST....
► Artikel lesen
11.07.Eloxx Pharmaceuticals Provides Pipeline and Financing Updates230First two subjects dosed in Phase 1 clinical trial of ZKN-013; ZKN-013 is being developed for the potential treatment of rare dermatological and other diseases associated with nonsense mutations ...
► Artikel lesen
Seite:  Weiter >>